Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postpartum Magnesium Sulfate Duration in Severe Preeclampsia
NCT02317146Phase 3Completed
- Sponsor
- Complejo Hospitalario Dr. Arnulfo Arias Madrid
- Start
- Nov 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of magnesium sulfate in preeclampsia (2 arms), sponsored by Complejo Hospitalario Dr. Arnulfo Arias Madrid. Primary endpoint: Seizure (Eclampsia). Started Nov 2013; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT02317146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02317146.